Figures computed from official regulatory filings — .
Ownershipinsiders 1.9% · institutions 7.91% · short 0.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ESCALON MEDICAL CORP only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. The company was incorporated in 1987 and is based in Wayne, Pennsylvania.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
46 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| DEPIANO RICHARD J | OtherD (derivative) | $491.2K | SEC | ||
| DEPIANO RICHARD J |
| OtherD (derivative) |
| $148.8K |
| SEC |
| Closkey C Sean | AwardD (derivative) | $1.6K | SEC |
| Trusk C Todd | AwardD (derivative) | $5.5K | SEC |
| DEPIANO RICHARD J | AwardD (derivative) | $7.9K | SEC |
| NAPOLITANO LISA A | AwardD (derivative) | $1.6K | SEC |
| O'Connor Robert Michael | AwardD (derivative) | $55K | SEC |
| DePiano Richard J Jr | AwardD (derivative) | $70.7K | SEC |
| Closkey C Sean | AwardD (derivative) | $7.9K | SEC |
| Closkey C Sean | AwardD (derivative) | $3.1K | SEC |
| Wallace Mark | AwardD (derivative) | $55K | SEC |
| DEPIANO RICHARD J | AwardD (derivative) | $15.7K | SEC |
| CHOATE FRED G | AwardD (derivative) | $3.1K | SEC |
| NAPOLITANO LISA A | AwardD (derivative) | $3.1K | SEC |
| DePiano Richard J Jr | Other | $540 | SEC |
| Wallace Mark | AwardD (derivative) | $15.1K | SEC |
| DePiano Richard J Jr | AwardD (derivative) | $18.1K | SEC |
| DEPIANO RICHARD J | AwardD (derivative) | $30.2K | SEC |
| O'Connor Robert Michael | AwardD (derivative) | $21.1K | SEC |
| FEDERMAN JAY L MD | AwardD (derivative) | $22.2K | SEC |
| DePiano Richard J Jr | AwardD (derivative) | $44.4K | SEC |
| O'Connor Robert Michael | AwardD (derivative) | $44.4K | SEC |
| COPPOLA ANTHONY J | AwardD (derivative) | $22.2K | SEC |
| NAPOLITANO LISA A | AwardD (derivative) | $22.2K | SEC |
| CHOATE FRED G | AwardD (derivative) | $22.2K | SEC |